Tapewire

Nasdaq · USD

AKBA

Akebia Therapeutics, Inc.

Export transactions ↓
Tapewire entity
6105
SEC CIK
0001517022
Parsed reports
275

Last 12 months

Inside the activity.

1 purchase rows · 16 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 2026015
Mar 202610
Apr 202600
May 202600
Jun 202601
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 10, 2025 Filed Jun 11, 2025 21:14 UTC GrantStock Option (Right to buy) · Derivative 53,600 $0.00 Strike: $3.92 $0.00
Disclosure

SEC source: 0001562180-25-004720 · primarydocument.xml · derivative · entry 2

ROGERS MICHAEL W · CIK 0001244159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,600

Underlying: Common Stock · 53,600 shares

Expires 2035-06-10

F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 10, 2025 Filed Jun 11, 2025 21:14 UTC GrantCommon Stock 35,700 $0.00 $0.00
Disclosure

SEC source: 0001562180-25-004720 · primarydocument.xml · nonDerivative · entry 1

ROGERS MICHAEL W · CIK 0001244159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 161,729

F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Fourth Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 10, 2025 Filed Jun 11, 2025 21:16 UTC GrantStock Option (Right to buy) · Derivative 53,600 $0.00 Strike: $3.92 $0.00
Disclosure

SEC source: 0001562180-25-004724 · primarydocument.xml · derivative · entry 2

ZUMWALT LEANNE M · CIK 0001204946 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,600

Underlying: Common Stock · 53,600 shares

Expires 2035-06-10

F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 10, 2025 Filed Jun 11, 2025 21:16 UTC GrantCommon Stock 35,700 $0.00 $0.00
Disclosure

SEC source: 0001562180-25-004724 · primarydocument.xml · nonDerivative · entry 1

ZUMWALT LEANNE M · CIK 0001204946 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 109,400

F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Fourth Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 10, 2025 Filed Jun 11, 2025 17:14 UTC GrantStock Option (Right to buy) · Derivative 53,600 $0.00 Strike: $3.92 $0.00
Disclosure

SEC source: 0001562180-25-004719 · primarydocument.xml · derivative · entry 2

GILMAN STEVEN C · CIK 0001379970 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,600

Underlying: Common Stock · 53,600 shares

Expires 2035-06-10

F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 10, 2025 Filed Jun 11, 2025 17:14 UTC GrantCommon Stock 35,700 $0.00 $0.00
Disclosure

SEC source: 0001562180-25-004719 · primarydocument.xml · nonDerivative · entry 1

GILMAN STEVEN C · CIK 0001379970 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 152,830

F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Fourth Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 10, 2025 Filed Jun 11, 2025 21:15 UTC GrantStock Option (Right to buy) · Derivative 53,600 $0.00 Strike: $3.92 $0.00
Disclosure

SEC source: 0001562180-25-004721 · primarydocument.xml · derivative · entry 2

Smith Cynthia · CIK 0001609480 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,600

Underlying: Common Stock · 53,600 shares

Expires 2035-06-10

F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 10, 2025 Filed Jun 11, 2025 21:15 UTC GrantCommon Stock 35,700 $0.00 $0.00
Disclosure

SEC source: 0001562180-25-004721 · primarydocument.xml · nonDerivative · entry 1

Smith Cynthia · CIK 0001609480 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,933

F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Fourth Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 10, 2025 Filed Jun 11, 2025 21:13 UTC
FRIESON RONDirector
GrantStock Option (Right to buy) · Derivative 53,600 $0.00 Strike: $3.92 $0.00
Disclosure

SEC source: 0001562180-25-004718 · primarydocument.xml · derivative · entry 2

FRIESON RON · CIK 0001890219 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,600

Underlying: Common Stock · 53,600 shares

Expires 2035-06-10

F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 10, 2025 Filed Jun 11, 2025 21:13 UTC
FRIESON RONDirector
GrantCommon Stock 35,700 $0.00 $0.00
Disclosure

SEC source: 0001562180-25-004718 · primarydocument.xml · nonDerivative · entry 1

FRIESON RON · CIK 0001890219 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 129,500

F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Fourth Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 09, 2025 Filed Jun 11, 2025 21:13 UTC
Malabre Richard CSVP, Chief Accounting Officer
Exercise / conversionStock Option (Right to buy) · Derivative 15,000 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001562180-25-004717 · primarydocument.xml · derivative · entry 3

Malabre Richard C · CIK 0002007730 · SVP, Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 321,000

Underlying: Common Stock · 15,000 shares

Expires 2034-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This stock option exercise was made pursuant to a Rule 10b5-1 Non-Discretionary Option Exercise and Stock Sale Plan adopted by the reporting person on December 12, 2024.

F4 · derivative.exercise_date: The options were granted by the Issuer as an inducement material to the reporting person's entering into employment with the Issuer in accordance with Nasdaq Listing Rule 5635(c)(4). The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
June 09, 2025 Filed Jun 11, 2025 21:13 UTC
Malabre Richard CSVP, Chief Accounting Officer
SaleCommon Stock 15,000 $4.01 $60,150.00
Disclosure

SEC source: 0001562180-25-004717 · primarydocument.xml · nonDerivative · entry 2

Malabre Richard C · CIK 0002007730 · SVP, Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 266,914

F2 · shares: This sale was made pursuant to a Rule 10b5-1 Non-Discretionary Option Exercise and Stock Sale Plan adopted by the reporting person on December 12, 2024.

F3 · price: The shares were sold at prices ranging from $4.00 to $4.03 and the price reported reflects the weighted average sale price.

Read SEC document
June 09, 2025 Filed Jun 11, 2025 21:13 UTC
Malabre Richard CSVP, Chief Accounting Officer
Exercise / conversionCommon Stock 15,000 $1.68 $25,200.00
Disclosure

SEC source: 0001562180-25-004717 · primarydocument.xml · nonDerivative · entry 1

Malabre Richard C · CIK 0002007730 · SVP, Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 281,914

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This stock option exercise was made pursuant to a Rule 10b5-1 Non-Discretionary Option Exercise and Stock Sale Plan adopted by the reporting person on December 12, 2024.

Read SEC document
June 04, 2025 Filed Jun 5, 2025 20:35 UTC
Malabre Richard CSVP, Chief Accounting Officer
SaleCommon Stock 13,334 $3.53 $47,069.02
Disclosure

SEC source: 0001562180-25-004491 · primarydocument.xml · nonDerivative · entry 1

Malabre Richard C · CIK 0002007730 · SVP, Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 266,914

F1 · shares: This sale was made pursuant to a Rule 10b5-1 Non-Discretionary Option Exercise and Stock Sale Plan adopted by the Reporting Person on December 12, 2024.

F2 · price: The shares were sold at prices ranging from $3.50 to $3.60 and the price reported reflects the weighted average sale price.

Read SEC document
March 03, 2025 Filed Mar 4, 2025 22:05 UTC
Butler John P.Director · CEO and President
SaleCommon Stock 46,409 $1.83 $84,928.47
Disclosure

SEC source: 0001562180-25-001998 · primarydocument.xml · nonDerivative · entry 1

Butler John P. · CIK 0001591467 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,557,921

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2022.

F2 · shares: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2023.

Read SEC document
March 03, 2025 Filed Mar 4, 2025 22:04 UTC
Burke Steven KeithSVP, Chief Medical Officer
SaleCommon Stock 7,144 $1.83 $13,073.52
Disclosure

SEC source: 0001562180-25-001997 · primarydocument.xml · nonDerivative · entry 1

Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 809,090

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2022.

F2 · shares: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2023.

Read SEC document
February 03, 2025 Filed Feb 4, 2025 22:54 UTC
Butler John P.Director · CEO and President
SaleCommon Stock 97,982 $2.10 $205,762.20
Disclosure

SEC source: 0001562180-25-000917 · primarydocument.xml · nonDerivative · entry 3

Butler John P. · CIK 0001591467 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,604,330

F3 · shares: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2023.

F5 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2024.

Read SEC document
February 03, 2025 Filed Feb 4, 2025 22:54 UTC
Butler John P.Director · CEO and President
SaleCommon Stock 46,268 $2.10 $97,162.80
Disclosure

SEC source: 0001562180-25-000917 · primarydocument.xml · nonDerivative · entry 2

Butler John P. · CIK 0001591467 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,702,312

F3 · shares: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2023.

F4 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2023.

Read SEC document
February 03, 2025 Filed Feb 4, 2025 22:53 UTC
Burke Steven KeithSVP, Chief Medical Officer
SaleCommon Stock 27,236 $2.10 $57,195.60
Disclosure

SEC source: 0001562180-25-000916 · primarydocument.xml · nonDerivative · entry 3

Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 816,234

F4 · shares: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2023.

F5 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2024.

Read SEC document
February 03, 2025 Filed Feb 4, 2025 22:53 UTC
Burke Steven KeithSVP, Chief Medical Officer
SaleCommon Stock 23,270 $2.10 $48,867.00
Disclosure

SEC source: 0001562180-25-000916 · primarydocument.xml · nonDerivative · entry 2

Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 843,470

F3 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2023.

F4 · shares: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2023.

Read SEC document
February 03, 2025 Filed Feb 4, 2025 22:52 UTC
Malabre Richard CSVP, Chief Accounting Officer
SaleCommon Stock 30,202 $2.10 $63,424.20
Disclosure

SEC source: 0001562180-25-000915 · primarydocument.xml · nonDerivative · entry 2

Malabre Richard C · CIK 0002007730 · SVP, Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 280,248

F3 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2024.

F4 · shares: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2023.

Read SEC document
February 03, 2025 Filed Feb 4, 2025 22:51 UTC
Grund NicholasChief Commercial Officer
SaleCommon Stock 55,621 $2.10 $116,804.10
Disclosure

SEC source: 0001562180-25-000914 · primarydocument.xml · nonDerivative · entry 2

Grund Nicholas · CIK 0001661887 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 442,579

F2 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2024.

F3 · shares: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2024.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 22:54 UTC
Butler John P.Director · CEO and President
GrantStock Option (Right to buy) · Derivative 1,051,400 $0.00 Strike: $2.24 $0.00
Disclosure

SEC source: 0001562180-25-000917 · primarydocument.xml · derivative · entry 9

Butler John P. · CIK 0001591467 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,051,400

Underlying: Common Stock · 1,051,400 shares

Expires 2035-01-31

F7 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 22:54 UTC
Butler John P.Director · CEO and President
GrantPerformance Stock Units · Derivative 350,500 $0.00 $0.00
Disclosure

SEC source: 0001562180-25-000917 · primarydocument.xml · derivative · entry 8

Butler John P. · CIK 0001591467 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 350,500

Underlying: Common Stock · 350,500 shares

Expires 2027-01-31

F6 · derivative.exercise_price: Each Performance Stock Unit ("PSU") right represents a contingent right to receive one share of the Issuer's common stock. One-half of the total number of shares of common stock underlying the PSUs shall vest on each of (a) the later of (i) the first anniversary of the grant date and (ii) the date that the Compensation Committee certifies that the average closing price of the Issuer's common stock equals or exceeds $3.50 over a 30-day trading period, and (b) the later of (i) the first anniversary of the grant date and (ii) the date that the Compensation Committee certifies that the average closing price of the Issuer's common stock equals or exceeds $5.00 for over a 30-day trading period, subject to the reporting person's continued service with the Issuer through the applicable vesting date.

F6 · derivative.exercise_date: Each Performance Stock Unit ("PSU") right represents a contingent right to receive one share of the Issuer's common stock. One-half of the total number of shares of common stock underlying the PSUs shall vest on each of (a) the later of (i) the first anniversary of the grant date and (ii) the date that the Compensation Committee certifies that the average closing price of the Issuer's common stock equals or exceeds $3.50 over a 30-day trading period, and (b) the later of (i) the first anniversary of the grant date and (ii) the date that the Compensation Committee certifies that the average closing price of the Issuer's common stock equals or exceeds $5.00 for over a 30-day trading period, subject to the reporting person's continued service with the Issuer through the applicable vesting date.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 22:54 UTC
Butler John P.Director · CEO and President
GrantCommon Stock 701,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-25-000917 · primarydocument.xml · nonDerivative · entry 1

Butler John P. · CIK 0001591467 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,748,580

F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.

F2 · balance_after: Includes 1,500 shares of the Issuer's common stock purchased on June 28, 2024 and 1,500 shares of the Issuer's common stock purchased on December 31, 2024, each under the Issuer's Amended and Restated 2014 Employee Stock Purchase Plan.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 22:53 UTC
Burke Steven KeithSVP, Chief Medical Officer
GrantStock Option (Right to buy) · Derivative 292,300 $0.00 Strike: $2.24 $0.00
Disclosure

SEC source: 0001562180-25-000916 · primarydocument.xml · derivative · entry 4

Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 292,300

Underlying: Common Stock · 292,300 shares

Expires 2035-01-31

F6 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 22:53 UTC
Burke Steven KeithSVP, Chief Medical Officer
GrantCommon Stock 194,900 $0.00 $0.00
Disclosure

SEC source: 0001562180-25-000916 · primarydocument.xml · nonDerivative · entry 1

Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 866,740

F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.

F2 · balance_after: Includes 1,500 shares of the Issuer's common stock purchased on June 28, 2024 and 1,500 shares of the Issuer's common stock purchased on December 31, 2024, each under the Issuer's Amended and Restated 2014 Employee Stock Purchase Plan.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 22:52 UTC
Malabre Richard CSVP, Chief Accounting Officer
GrantStock Option (Right to buy) · Derivative 128,000 $0.00 Strike: $2.24 $0.00
Disclosure

SEC source: 0001562180-25-000915 · primarydocument.xml · derivative · entry 3

Malabre Richard C · CIK 0002007730 · SVP, Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 128,000

Underlying: Common Stock · 128,000 shares

Expires 2035-01-31

F5 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 22:52 UTC
Malabre Richard CSVP, Chief Accounting Officer
GrantCommon Stock 85,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-25-000915 · primarydocument.xml · nonDerivative · entry 1

Malabre Richard C · CIK 0002007730 · SVP, Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 310,450

F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.

F2 · balance_after: Includes 1,500 shares of the Issuer's common stock purchased on December 31, 2024 under the Issuer's Amended and Restated 2014 Employee Stock Purchase Plan.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 22:51 UTC
Grund NicholasChief Commercial Officer
GrantStock Option (Right to buy) · Derivative 292,300 $0.00 Strike: $2.24 $0.00
Disclosure

SEC source: 0001562180-25-000914 · primarydocument.xml · derivative · entry 3

Grund Nicholas · CIK 0001661887 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 292,300

Underlying: Common Stock · 292,300 shares

Expires 2035-01-31

F4 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 22:51 UTC
Grund NicholasChief Commercial Officer
GrantCommon Stock 194,900 $0.00 $0.00
Disclosure

SEC source: 0001562180-25-000914 · primarydocument.xml · nonDerivative · entry 1

Grund Nicholas · CIK 0001661887 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 498,200

F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 22:48 UTC
Ostrowski ErikSVP, CFO, CBO & Treasurer
GrantStock Option (Right to buy) · Derivative 292,300 $0.00 Strike: $2.24 $0.00
Disclosure

SEC source: 0001562180-25-000913 · primarydocument.xml · derivative · entry 2

Ostrowski Erik · CIK 0001762507 · SVP, CFO, CBO & Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 292,300

Underlying: Common Stock · 292,300 shares

Expires 2035-01-31

F2 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 22:48 UTC
Ostrowski ErikSVP, CFO, CBO & Treasurer
GrantCommon Stock 194,900 $0.00 $0.00
Disclosure

SEC source: 0001562180-25-000913 · primarydocument.xml · nonDerivative · entry 1

Ostrowski Erik · CIK 0001762507 · SVP, CFO, CBO & Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 544,900

F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
January 17, 2025 Filed Jan 22, 2025 21:06 UTC
FRIESON RONDirector
Exercise / conversionStock Option (Right to buy) · Derivative 20,100 $0.00 Strike: $0.45 $0.00
Disclosure

SEC source: 0001562180-25-000453 · primarydocument.xml · derivative · entry 2

FRIESON RON · CIK 0001890219 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,100 shares

Expires 2032-06-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 17, 2025 Filed Jan 22, 2025 21:06 UTC
FRIESON RONDirector
Exercise / conversionCommon Stock 20,100 $0.45 $9,045.00
Disclosure

SEC source: 0001562180-25-000453 · primarydocument.xml · nonDerivative · entry 1

FRIESON RON · CIK 0001890219 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,800

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 28, 2024 Filed Jul 2, 2024 20:31 UTC
Ostrowski ErikSVP, CFO, CBO & Treasurer
GrantStock Option (Right to buy) · Derivative 500,000 $0.00 Strike: $1.02 $0.00
Disclosure

SEC source: 0001562180-24-005516 · primarydocument.xml · derivative · entry 2

Ostrowski Erik · CIK 0001762507 · SVP, CFO, CBO & Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2034-06-28

F2 · derivative.exercise_date: The options were granted by the Issuer as an inducement material to the Reporting Person's entering into employment with the Issuer in accordance with Nasdaq Listing Rule 5635(c)(4). The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each vesting date.

Read SEC document
June 28, 2024 Filed Jul 2, 2024 20:31 UTC
Ostrowski ErikSVP, CFO, CBO & Treasurer
GrantCommon Stock 350,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-24-005516 · primarydocument.xml · nonDerivative · entry 1

Ostrowski Erik · CIK 0001762507 · SVP, CFO, CBO & Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 350,000

F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. One third of the RSUs will vest upon each of the first, second and third anniversaries of the grant date, subject to the Reporting Person's continued service with the Issuer on each vesting date.

Read SEC document
June 06, 2024 Filed Jun 10, 2024 20:20 UTC
Wolf MylesDirector
GrantStock Option (Right to buy) · Derivative 45,000 $0.00 Strike: $1.07 $0.00
Disclosure

SEC source: 0001562180-24-004910 · primarydocument.xml · derivative · entry 2

Wolf Myles · CIK 0001808317 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2034-06-06

F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 06, 2024 Filed Jun 10, 2024 20:20 UTC
Wolf MylesDirector
GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-24-004910 · primarydocument.xml · nonDerivative · entry 1

Wolf Myles · CIK 0001808317 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,681

F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Third Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 06, 2024 Filed Jun 10, 2024 20:18 UTC
ADAMS ADRIANDirector
GrantStock Option (Right to buy) · Derivative 45,000 $0.00 Strike: $1.07 $0.00
Disclosure

SEC source: 0001562180-24-004901 · primarydocument.xml · derivative · entry 2

ADAMS ADRIAN · CIK 0001248144 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2034-06-06

F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 06, 2024 Filed Jun 10, 2024 20:18 UTC
ADAMS ADRIANDirector
GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-24-004901 · primarydocument.xml · nonDerivative · entry 1

ADAMS ADRIAN · CIK 0001248144 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 164,800

F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Third Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 06, 2024 Filed Jun 10, 2024 20:19 UTC GrantStock Option (Right to buy) · Derivative 45,000 $0.00 Strike: $1.07 $0.00
Disclosure

SEC source: 0001562180-24-004907 · primarydocument.xml · derivative · entry 2

ROGERS MICHAEL W · CIK 0001244159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2034-06-06

F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 06, 2024 Filed Jun 10, 2024 20:19 UTC GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-24-004907 · primarydocument.xml · nonDerivative · entry 1

ROGERS MICHAEL W · CIK 0001244159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 126,029

F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Third Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 06, 2024 Filed Jun 10, 2024 20:18 UTC GrantStock Option (Right to buy) · Derivative 45,000 $0.00 Strike: $1.07 $0.00
Disclosure

SEC source: 0001562180-24-004904 · primarydocument.xml · derivative · entry 2

ZUMWALT LEANNE M · CIK 0001204946 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2034-06-06

F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 06, 2024 Filed Jun 10, 2024 20:18 UTC GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-24-004904 · primarydocument.xml · nonDerivative · entry 1

ZUMWALT LEANNE M · CIK 0001204946 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,700

F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Third Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 06, 2024 Filed Jun 10, 2024 16:19 UTC GrantStock Option (Right to buy) · Derivative 45,000 $0.00 Strike: $1.07 $0.00
Disclosure

SEC source: 0001562180-24-004906 · primarydocument.xml · derivative · entry 2

GILMAN STEVEN C · CIK 0001379970 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2034-06-06

F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 06, 2024 Filed Jun 10, 2024 16:19 UTC GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-24-004906 · primarydocument.xml · nonDerivative · entry 1

GILMAN STEVEN C · CIK 0001379970 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 117,130

F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Third Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 06, 2024 Filed Jun 10, 2024 20:20 UTC GrantStock Option (Right to buy) · Derivative 45,000 $0.00 Strike: $1.07 $0.00
Disclosure

SEC source: 0001562180-24-004909 · primarydocument.xml · derivative · entry 2

Smith Cynthia · CIK 0001609480 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2034-06-06

F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 06, 2024 Filed Jun 10, 2024 20:20 UTC GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-24-004909 · primarydocument.xml · nonDerivative · entry 1

Smith Cynthia · CIK 0001609480 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,233

F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Third Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 06, 2024 Filed Jun 10, 2024 20:19 UTC
FRIESON RONDirector
GrantStock Option (Right to buy) · Derivative 45,000 $0.00 Strike: $1.07 $0.00
Disclosure

SEC source: 0001562180-24-004905 · primarydocument.xml · derivative · entry 2

FRIESON RON · CIK 0001890219 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2034-06-06

F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.